138 related articles for article (PubMed ID: 92331)
1. Tumour markers in breast cancer.
Cove DH; Woods KL; Smith SC; Burnett D; Leonard J; Grieve RJ; Howell A
Br J Cancer; 1979 Nov; 40(5):710-8. PubMed ID: 92331
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of clinical chemistry measurements in classifying patients with breast cancer.
Statland BE; Winkel P
Crit Rev Clin Lab Sci; 1982; 16(4):255-90. PubMed ID: 6749428
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
4. [Serum levels of carcinoembryonic antigen (CEA) and pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast cancer].
Kimoto A; Uemura K; Egami T; Kawaguchi H; Goto H; Miyauchi Y; Yokoyama I
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2022-8. PubMed ID: 7169574
[No Abstract] [Full Text] [Related]
5. [Human breast cancer markers].
Remennik LV
Eksp Onkol; 1985; 7(4):3-8. PubMed ID: 2994992
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and prognosis of breast lesions. Value of 3 immunological markers: fibronectin, carcinoembryonic antigen and bovine lactalbumin. Study of 40 cases].
Canioni D; Kermarec J
Arch Anat Cytol Pathol; 1984; 32(4):235-42. PubMed ID: 6508376
[No Abstract] [Full Text] [Related]
7. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
Shimizu Y; Oshima K; Nakano Y; Fujita M; Taguchi T
Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
[TBL] [Abstract][Full Text] [Related]
8. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study.
Lee AK; Rosen PP; DeLellis RA; Saigo PE; Gangi MD; Groshen S; Bagin R; Wolfe HJ
Am J Clin Pathol; 1985 Dec; 84(6):687-96. PubMed ID: 3878077
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy-associated plasma protein A and extensive necrosis. Clinically significant predictors of early recurrence in stage I estrogen receptor-negative breast carcinoma.
Kuhajda FP; Eggleston JC
Lab Invest; 1985 Jul; 53(1):101-7. PubMed ID: 2409349
[TBL] [Abstract][Full Text] [Related]
10. Search for biological markers in breast cancer.
Mach JP; Fritsche R; Phan M; Ozzello L; Stjernsward J
Prog Clin Biol Res; 1977; 12():91-108. PubMed ID: 72388
[No Abstract] [Full Text] [Related]
11. Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin.
Waalkes TP; Gehrke CW; Tormey DC; Woo KB; Kuo KC; Synder J; Hansen H
Cancer; 1978 May; 41(5):1871-82. PubMed ID: 647632
[TBL] [Abstract][Full Text] [Related]
12. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
Harach HR; Skinner M; Gibbs AR
Thorax; 1983 Dec; 38(12):937-41. PubMed ID: 6198740
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical detection of tumour markers in bone metastases from carcinoma of the breast.
Gugliotta P; Botta G; Bussolati G
Histochem J; 1981 Nov; 13(6):953-9. PubMed ID: 6978331
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen and other tumor markers in tissue and serum or plasma of patients with primary mammary carcinoma.
Wahren B; Lidbrink E; Wallgren A; Eneroth P; Zajicek J
Cancer; 1978 Oct; 42(4):1870-8. PubMed ID: 361213
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.
Stacker SA; Sacks NP; Golder J; Tjandra JJ; Thompson CH; Smithyman A; McKenzie IF
Br J Cancer; 1988 Mar; 57(3):298-303. PubMed ID: 3355770
[TBL] [Abstract][Full Text] [Related]
16. Biologic markers and breast cancer.
Waalkes TP; Tormey DC
Semin Oncol; 1978 Dec; 5(4):434-44. PubMed ID: 83677
[No Abstract] [Full Text] [Related]
17. Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.
Gibbs AR; Harach R; Wagner JC; Jasani B
Thorax; 1985 Feb; 40(2):91-5. PubMed ID: 2579450
[TBL] [Abstract][Full Text] [Related]
18. Biological markers in human breast carcinoma.
Walker RA
J Pathol; 1982 Jun; 137(2):109-17. PubMed ID: 7045309
[TBL] [Abstract][Full Text] [Related]
19. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
Villani C
Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Arora B; Chhabra A; Yadav MS; Arora DR
Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
